Skip to main content
. 2013 Sep 16;4:10.3402/dfa.v4i0.22081. doi: 10.3402/dfa.v4i0.22081

Table 1.

Perfusion randomized controlled trial (RCT) organized by the type of ulcer

Author Pathology of interest Duration of treatment Treatment specification: voltage, current, phase duration, frequency Population Outcome
Gilcreast (45) Perfusion in DFU and high-risk population using HPVC Once
Span: 1 day
100 V, 100 pps, 0.07 pulse duration Treatment n=132 TcpO2 significant improvement in 27% of subjects (p<0.05). No change in 73% of study subjects.
Laser Doppler flow NS.
Capillary density NS.
Clover (35) Perfusion in stable claudication using TENS 1 hour, TID, for 6 weeks
Span: 6 weeks
1.0 V, 10 mA, 8 Hz Treatment n=24, Control: n=12 Capillary density increased treatment 25% vs. control 0% p<0.005
TcpO2 was greater in treatment group vs. control, p>0.05, raw value NS.
Laser Doppler flow NS.
Cramp (36) Perfusion in health humans using TENS Once, 15 min
Span: 1 day
High frequency = 110 Hz, 200 µs
Low frequency 4 Hz, 200 µs
High frequency n=10
Low frequency n=10
Sham** n=10
TcpO2 NS.
Laser Doppler blood flow was greater in the low-frequency group compared vs. other groups p=0.01.
Capillary density NS.
Forst (46) Perfusion in neuropathic patients using TENS Once, 3 min
Span: 1 day
0.2 ms at 4 cycles/s 70 mA or painless muscle contraction NP-/RP− n=14, NP + /RP− n=14, NP − /RP+ n=8, NP + /RP + n=21,
Non-diabetic n=21
TcpO2 NS.
Laser Doppler blood flow increased with ES in all groups at the dorsum of the foot p>0.05.
Capillary density NS.
Peters (44) Perfusion in diabetics using DC 60 min, QID, for 1 day
Span: 2 days
50 V, 100 twin-peak monophasic pps Diabetics with PAD n= 11
and without PAD n=8
TcpO2 significant improvement in patients with PAD 27% (p<0.05) No change in patients without PAD.
Laser Doppler blood flow no difference (p=0.27)
Capillary density NS.
Griffin (41) Venous flow with TENS Twelve increments in stimuli per minute (spm) 0–5 V, 50 ms, 2–120 spm Healthy volunteers n = 24 Peak systolic velocity in popliteal artery was 10 times higher at 2–8 spm than baseline
Ejection volume was 19 times higher at spm than 120 spm.

* Single-blind RCT;

**

double-blind RCT; NS, not stated; pps: pulse per second.

HHS Vulnerability Disclosure